• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 30, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Two medications from Kazan University awarded at International Exhibition of Inventions

Bioengineer by Bioengineer
April 16, 2019
in Chemistry
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The event took place on April 10-14

The compounds are among the eight prospective medications developed by Kazan University’s Pharmaceutics Center.

Codename KFU-01 is a dipharmacophore, i. e. a framework of two active components which work in tandem after getting into the organism. The compound has shown significant advantages over all existing analogs in treating locomotor ailments.

Codename KFU-02 is a platform technology based on a reuptake inhibitor aimed at boosting the effectiveness of tumor treatment without chemotherapy.

Companies-residents of Skolkovo Innovation Center have been established to promote both medications. Russian and international patents have been registered. Clinical trials are expected to commence in Russia in 2019.

After evaluating over 70 exhibits in biomedicine, Geneva Exhibition committee gave both projects gold medals. They also received commendation from Russian Patent Service and national delegations of Taiwan and Iran.

According to KFU-01 and KFU-02 project leader, Director of Pharmaceutics Center Yury Shtyrlin, the medals mean that both medications have reached global awareness, which stimulates further intensive work.

###

Media Contact
Yury Nurmeev
[email protected]
https://kpfu.ru/eng/news-eng/geneva-exhibition-gold-medals.html

Tags: cancerMedicine/HealthOrthopedic MedicinePharmaceutical Science
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Ultrafast Polaron Formation in NaTaO3 Reveals Instant Stabilization of Positive Charges in Key Solar Fuel Catalyst

September 30, 2025
blank

New Supramolecular Elastomer with Boron-Based Dynamic Bonds Delivers Superior Mechanical Strength and Chemical Recovery

September 30, 2025

New Study Uncovers Why Modern Proteins Were Selected by Nature

September 29, 2025

Global Call to Advance Robust and Reproducible Polyphenol Research to Launch Next October in Malta at Polyphenols Applications World Congress and Iprona

September 29, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    87 shares
    Share 35 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    73 shares
    Share 29 Tweet 18
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    59 shares
    Share 24 Tweet 15
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Ultra-Linear Ga2O3 Synapses Enable Neuromorphic Vision

Study Finds Retraining After Endurance Exercise Break Boosts Muscle Gains

Transforming Healthcare: The TRIL Nurse Advocacy Model

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.